Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Bauer

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 29, 2021
Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysisViola W Zhu, Joseph J Zhao, Yanfei Gao, et al.
Thrombosis and Haemostasis|January 10, 2009
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)Alexander G G Turpie, Kenneth A Bauer, Bruce L Davidson, et al.
Journal of the American Geriatrics Society|October 3, 2013
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminarSteven A Lubitz, Kenneth A Bauer, Emelia J Benjamin, et al.
Blood|May 11, 2006
The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer sizeJeffrey I Zwicker, Flora Peyvandi, Roberta Palla, et al.
American Journal of Hematology|July 14, 2020
Heparin induced thrombocytopenia antibodies in Covid-19Rushad Patell, Adeel M Khan, Thomas Bogue, et al.
Blood Advances|May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trialJeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 11, 2010
Polymorphisms in the factor VII gene and ischemic stroke in young adultsStanislaw Lopaciuk, Jerzy Windyga, Cezary W Watala, et al.
Critical Pathways in Cardiology|March 11, 2010
The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical educationGowthami Arepally, Kenneth A Bauer, Deepak L Bhatt, et al.
Blood|March 18, 2024
Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK BiobankJustine Ryu, Joel T Rämö, Sean J Jurgens, et al.
American Journal of Clinical Pathology|December 6, 2006
Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patientsOlivier Kocher, Christine Cirovic, Elizabeth Malynn, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Lung Cancer (Amsterdam, Netherlands)|May 29, 2021
Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysisViola W Zhu, Joseph J Zhao, Yanfei Gao, et al.
Thrombosis and Haemostasis|January 10, 2009
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT)Alexander G G Turpie, Kenneth A Bauer, Bruce L Davidson, et al.
Journal of the American Geriatrics Society|October 3, 2013
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminarSteven A Lubitz, Kenneth A Bauer, Emelia J Benjamin, et al.
Blood|May 11, 2006
The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer sizeJeffrey I Zwicker, Flora Peyvandi, Roberta Palla, et al.
American Journal of Hematology|July 14, 2020
Heparin induced thrombocytopenia antibodies in Covid-19Rushad Patell, Adeel M Khan, Thomas Bogue, et al.
Blood Advances|May 23, 2020
Dose-adjusted enoxaparin thromboprophylaxis in hospitalized cancer patients: a randomized, double-blinded multicenter phase 2 trialJeffrey I Zwicker, Joanna Roopkumar, Maneka Puligandla, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 11, 2010
Polymorphisms in the factor VII gene and ischemic stroke in young adultsStanislaw Lopaciuk, Jerzy Windyga, Cezary W Watala, et al.
Critical Pathways in Cardiology|March 11, 2010
The use of antithrombotic therapies in the prevention and treatment of arterial and venous thrombosis: a survey of current knowledge and practice supporting the need for clinical educationGowthami Arepally, Kenneth A Bauer, Deepak L Bhatt, et al.
Blood|March 18, 2024
Thrombosis risk in single- and double-heterozygous carriers of factor V Leiden and prothrombin G20210A in FinnGen and the UK BiobankJustine Ryu, Joel T Rämö, Sean J Jurgens, et al.
American Journal of Clinical Pathology|December 6, 2006
Obstetric complications in patients with hereditary thrombophilia identified using the LCx microparticle enzyme immunoassay: a controlled study of 5,000 patientsOlivier Kocher, Christine Cirovic, Elizabeth Malynn, et al.
Pageof 10